Abstract:BACKGROUND:Implantation of current used bare metal stent,metal drug-eluting stent,or alloy stent would result in local intimal hyperplasia,thrombosis and increase incidence of adverse cardiovascular event. Therefore,the development and preparation of high molecular polymer biodegradable stent has aroused increasing attention. OBJECTIVE:To study the behavior and histocompatibility of novel fully biodegradable material of poly trimethylene carbonate-co-d,l-lactide(PDLLA/TMC) in vivo. METHODS:The early-stage synthetized materials of PDLLA/TMC(50/50) were used in the experiment group and the PLLA/TMC(50/50) and PLLA in the control. The patches of each kind of the three polymers above were implanted into the subcutaneous tissue of the 144 Wistar mouse with equal gender,six months old. The polymers patches and their surrounding tissues were taken out and weighed and sliced for hematoxylin-esoin staining at the phases of different test time. Their biodegradable behaviors in vivo were tested by the methods of size exclusion chromatography(SEC) ,gel permeation chromatography(GPC) ,nuclear magnetic resonance(NMR) and environmental scanning electron microscope(ESEM) ,and their histocompatibility was evaluated by inflammation cells counting in quantity with light microscope. RESULTS AND CONCLUSION:In the first 60 days of implantation,there was no significant difference in the percentage of mass loss among the three groups,and their velocity of degradation was relatively slow,though it was slightly faster in the PDLLA/TMC than in the PLLA/TMC and PLLA. During the 60 days to 180 days,PDLA/TMC degradation velocity accelerated obviously,and its percentage of mass loss was much higher than the other two polymers. At 180 days,most of the PDLLA/TMC degraded while the PLLA/TMC and PLLA degraded less. When the three polymers were implanted into the mouse body,at first their molecular declined rapidly,then the decline went into a slow stage gradually. With the time extended,their smooth and orderly superficial structure transformed into ruffle,twist,turbulent,full of hole and hollow,which was rather obvious in the polymer of PDLLA/TMC. Also,there were relative lower inflammation cells counting in the PDLLA/TMC and PLLA/TMC group at the phase of different test time,compared to the PLLA group the differences had statistic significance(P < 0.05) ,but there was no statistic significance between the PDLLA/TMC and PLLA/TMC group(P > 0.05) . The polymer of PDLLA/TMC,which has favorable degradation performance and histocopatibility,is a novel fully biodegradable material and capable of manufacturing the implanted cardiovascular stent.

Evaluation of Hemocompatibility of a New Biopolymer Material for Bioabsorbable Stents Used for Children with Vascular Stenosis in Vitro

Cytocompatibility Evaluation of a Novel Series of PEG-Functionalized Lactide-Caprolactone Copolymer Biomaterials for Cardiovascular Applications

Dynamic Mechanical Properties of Biodegradable Stents

In Vitro Biocompatibility Evaluation of Bioresorbable Copolymers Prepared from L-Lactide, 1, 3-Trimethylene Carbonate, and Glycolide for Cardiovascular Applications

Mechanical properties and in vivo performance of a novel sliding-lock bioabsorbable poly- p -dioxanone stent

Study on in vivo and in vitro degradation of polydioxanone weaving tracheal stents

Study onin vivoandin vitrodegradation of polydioxanone weaving tracheal stents.

In vivo degradation behavior and histocompatibility of a novel fully biodegradable material:Poly trimethylene carbonate-Co-D,L-Lactide

3D-Printed Poly (P-Dioxanone) Stent for Endovascular Application: In Vitro Evaluations

Haemo- and cytocompatibility of bioresorbable homo- and copolymers prepared from 1,3-trimethylene carbonate, lactides, and ε-caprolactone

A Novel Braided Biodegradable Stent for Use in Congenital Heart Disease: Short-term Results in Porcine Iliac Artery

In vitro and in vivo evaluation of degradability and biocompatibility of poly(p‐dioxanone) hemostatic clips for laparoscopic surgery

Electrospun bioresorbable polymer membranes for coronary artery stents

3D-Printed Poly(p-Dioxanone)/graphene Oxide Composite Bioresorbable Stents for Congenital Heart Disease Treatment

Composite self-expanding bioresorbable prototype stents with reinforced compression performance for congenital heart disease application: Computational and experimental investigation

New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets

Coronary Bioresorbable metallic stents:Advancements and future perspectives

Biocompatibility Testing of A New Biodegradable Ureteral Stent

In vitro degradation behavior of poly （p-dioxanone) inside the simulated body environment

A fully biodegradable polydioxanone occluder for ventricle septal defect closure

Bioresorbable PPDO Sliding-Lock Stents with Optimized FDM Parameters for Congenital Heart Disease Treatment.